Page last updated: 2024-09-04

gadolinium dtpa and edotreotide

gadolinium dtpa has been researched along with edotreotide in 2 studies

Compound Research Comparison

Studies (gadolinium dtpa)	Trials (gadolinium dtpa)	Recent Studies (post-2010) (gadolinium dtpa)	Studies (edotreotide)	Trials (edotreotide)	Recent Studies (post-2010) (edotreotide)
12,654	664	4,051	206	34	86

Protein Interaction Comparison

Protein	Taxonomy	edotreotide (IC50)
Somatostatin receptor type 2	Homo sapiens (human)	0.014
Somatostatin receptor type 3	Homo sapiens (human)	0.88
Somatostatin receptor type 5	Homo sapiens (human)	0.393

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Giesel, FL; Haberkorn, U; Kauczor, HU; Kratochwil, C; Ley, S; Mehndiratta, A; Moltz, JH; Wulfert, S; Zechmann, CM	1
Collins, DJ; d'Arcy, JA; Davidson, RL; Koh, DM; Koh, TS; Leach, MO; Lewington, V; Miyazaki, K; Orton, MR; Thng, CH	1

Trials

1 trial(s) available for gadolinium dtpa and edotreotide

Article	Year
Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI. European journal of radiology, 2012, Volume: 81, Issue:10 Topics: Contrast Media; Female; Gadolinium DTPA; Humans; Indium Radioisotopes; Iopamidol; Magnetic Resonance Imaging; Male; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed	2012

Article

Year

Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.

European journal of radiology, 2012, Volume: 81, Issue:10

Topics: Contrast Media; Female; Gadolinium DTPA; Humans; Indium Radioisotopes; Iopamidol; Magnetic Resonance Imaging; Male; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed

2012

Other Studies

1 other study(ies) available for gadolinium dtpa and edotreotide

Article	Year
Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response. Radiology, 2012, Volume: 263, Issue:1 Topics: Adult; Aged; Area Under Curve; Contrast Media; Discriminant Analysis; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Survival Rate; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2012

Article

Year

Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response.

Radiology, 2012, Volume: 263, Issue:1

Topics: Adult; Aged; Area Under Curve; Contrast Media; Discriminant Analysis; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Survival Rate; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2012